[
  {
    "ts": null,
    "headline": "Vertex Pharmaceuticals (VRTX) Ascends While Market Falls: Some Facts to Note",
    "summary": "In the closing of the recent trading day, Vertex Pharmaceuticals (VRTX) stood at $381.87, denoting a +1.39% move from the preceding trading day.",
    "url": "https://finnhub.io/api/news?id=4f96bc05cb7811a76d5a69f8e4728dcc5a277fa285091e1de89f58fbaffa7e94",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758837605,
      "headline": "Vertex Pharmaceuticals (VRTX) Ascends While Market Falls: Some Facts to Note",
      "id": 136888402,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "In the closing of the recent trading day, Vertex Pharmaceuticals (VRTX) stood at $381.87, denoting a +1.39% move from the preceding trading day.",
      "url": "https://finnhub.io/api/news?id=4f96bc05cb7811a76d5a69f8e4728dcc5a277fa285091e1de89f58fbaffa7e94"
    }
  },
  {
    "ts": null,
    "headline": "Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
    "summary": "Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=210d3ec37aeec087012cfbe6cc6b8222c914a6085803d5963d2013e6c94ef8d1",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758818400,
      "headline": "Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
      "id": 136924842,
      "image": "",
      "related": "VRTX",
      "source": "MarketWatch",
      "summary": "Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=210d3ec37aeec087012cfbe6cc6b8222c914a6085803d5963d2013e6c94ef8d1"
    }
  },
  {
    "ts": null,
    "headline": "Vertex Pharmaceuticals: Trikafta And Alyftrek Cement Market Leadership",
    "summary": "Vertex Pharmaceuticals: Trikafta And Alyftrek Cement Market Leadership",
    "url": "https://finnhub.io/api/news?id=129f1b6e3d24c653cdd2b2626d0b292f1911daeb77bb859481afd6de83be93ac",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758807579,
      "headline": "Vertex Pharmaceuticals: Trikafta And Alyftrek Cement Market Leadership",
      "id": 136885142,
      "image": "",
      "related": "VRTX",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=129f1b6e3d24c653cdd2b2626d0b292f1911daeb77bb859481afd6de83be93ac"
    }
  },
  {
    "ts": null,
    "headline": "Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know",
    "summary": "Zacks.com users have recently been watching Vertex (VRTX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",
    "url": "https://finnhub.io/api/news?id=453b85576c7e9ebfac9970c929c2097fecba196ac47700d4fd28e67cab3cf995",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758805204,
      "headline": "Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know",
      "id": 136883260,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "Zacks.com users have recently been watching Vertex (VRTX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",
      "url": "https://finnhub.io/api/news?id=453b85576c7e9ebfac9970c929c2097fecba196ac47700d4fd28e67cab3cf995"
    }
  },
  {
    "ts": null,
    "headline": "Vertex Announces Key Advancements Across Kidney Portfolio",
    "summary": "BOSTON, September 25, 2025--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced several important advancements across its programs in immunoglobulin A Nephropathy (IgAN), APOL1-mediated kidney disease (AMKD) and autosomal dominant polycystic kidney disease (ADPKD). These updates represent significant progress toward reaching the Company’s goal of bringing forward first-in-class or best-in-class therapies that target the underlying cause of these serious kidney diseases.",
    "url": "https://finnhub.io/api/news?id=aad4eb10f98afa35a33e264ab34f9c0973b9013af4bdc57ae5c66a65e15b0bf1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758800700,
      "headline": "Vertex Announces Key Advancements Across Kidney Portfolio",
      "id": 136883261,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "BOSTON, September 25, 2025--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced several important advancements across its programs in immunoglobulin A Nephropathy (IgAN), APOL1-mediated kidney disease (AMKD) and autosomal dominant polycystic kidney disease (ADPKD). These updates represent significant progress toward reaching the Company’s goal of bringing forward first-in-class or best-in-class therapies that target the underlying cause of these serious kidney diseases.",
      "url": "https://finnhub.io/api/news?id=aad4eb10f98afa35a33e264ab34f9c0973b9013af4bdc57ae5c66a65e15b0bf1"
    }
  },
  {
    "ts": null,
    "headline": "My 3 Favorite Stocks to Buy Right Now",
    "summary": "Uncertainty is in the air. But these stocks inspire confidence.",
    "url": "https://finnhub.io/api/news?id=1c87c468f133adcf7dabaac849bf820710409c65bf6bc90e11c87ba346a10ea1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758789720,
      "headline": "My 3 Favorite Stocks to Buy Right Now",
      "id": 136883262,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "Uncertainty is in the air. But these stocks inspire confidence.",
      "url": "https://finnhub.io/api/news?id=1c87c468f133adcf7dabaac849bf820710409c65bf6bc90e11c87ba346a10ea1"
    }
  },
  {
    "ts": null,
    "headline": "FDA Grants Vertex Kidney Disease Drug Breakthrough Therapy Designation",
    "summary": "FDA Grants Vertex Kidney Disease Drug Breakthrough Therapy Designation",
    "url": "https://finnhub.io/api/news?id=ccf1ce082f1f136ad10662dae5697f231e85af48de2da4dac7f2792b9b3d4e36",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758787800,
      "headline": "FDA Grants Vertex Kidney Disease Drug Breakthrough Therapy Designation",
      "id": 136924843,
      "image": "",
      "related": "VRTX",
      "source": "MarketWatch",
      "summary": "FDA Grants Vertex Kidney Disease Drug Breakthrough Therapy Designation",
      "url": "https://finnhub.io/api/news?id=ccf1ce082f1f136ad10662dae5697f231e85af48de2da4dac7f2792b9b3d4e36"
    }
  }
]